what is a glp-1 agonist PDB-101: Molecule of the Month: Receptor Agonists GLP-1 Medications for Weight Loss:

Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L

Nature Rev Endocrinol

It has been shown using various atherosclerosis animal models that GLP-1RA therapy is associated with a reduction in atherosclerotic plaques, prevention of aorta intima-media thickening, improvement in vascular endothelial function, reduction of the necrotic zone and an increase of the fibrous component in the plaque and plaque stabilisation

When compared to other antihyperglycemic agents, patients with type 2 diabetes receiving GLP-1RAs therapy exhibit a lower risk of developing colorectal cancer [45]

Diabetes and Infection: Review of the Epidemiology, Mechanisms and Principles of Treatment

Long-term bariatric surgery outcomes are consistently durable, with major societies noting sustained weight loss years after surgery